STOCK TITAN

ROIV (NASDAQ: ROIV) restricted stock vesting listed on Form 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC submitted a Form 144 notice for ROIV reporting restricted stock vesting events under a registered plan. The filing lists multiple vesting dates and per‑event share counts, including 13,580 shares vesting on 09/12/2024 and 14,745 shares vesting on 09/10/2025.

The entries are described as "Restricted stock vesting under a registered plan" with the issuer listed as the source of the vested shares. The filing documents the timing and share amounts of these compensation‑related vesting events rather than open‑market trades.

Positive

  • None.

Negative

  • None.

Insights

Filing documents scheduled restricted‑stock vesting events, not sales.

The notice lists multiple vesting events where shares vested under a registered plan on specific dates; the issuer is recorded as the source. These are compensation issuances tied to service, shown as dated vesting entries (examples: 13,580 shares on 09/12/2024; 14,745 shares on 09/10/2025).

Cash‑flow treatment or any subsequent disposition of the vested shares is not stated in the excerpt; subsequent filings would show sales if and when they occur. Timing and amounts are explicit per vesting date in the notice.

Entries reflect issuer‑sourced vesting under plan terms, a routine compensation record.

The listing characterizes each item as "Restricted stock vesting under a registered plan" and attributes the shares to the issuer. The pattern and labels align with compensation vesting events rather than transfers to third parties.

Regulatory implication: these notices document the availability of shares that could be sold later under applicable rules; the filing itself does not disclose any sales or proceeds.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does ROIV's Form 144 filing show?

It shows restricted stock vesting events under a registered plan for ROIV, listing specific vesting dates and share counts such as 13,580 (09/12/2024) and 14,745 (09/10/2025). The filing records vesting, not sales.

Does this Form 144 mean the shares were sold?

No. The excerpt lists shares as "Restricted stock vesting under a registered plan" with the issuer as source. It documents vesting events; any sale would appear in a separate transaction filing.

Who is the filer listed in the ROIV Form 144?

The filer is Morgan Stanley Smith Barney LLC Executive Financial Services, recorded as the submitting broker for the reported restricted stock vesting events on the listed dates.

How many vesting events are listed in the filing?

The filing lists multiple dated vesting events with per‑event share counts (examples include 1,047 to 14,745 shares across various dates). It enumerates each vesting date and amount rather than a single aggregate total.

Does the filing state proceeds or cash treatment for these shares?

No. The excerpt attributes the shares to the issuer and characterizes them as vesting under a plan; it does not disclose any proceeds, sales, or cash‑flow treatment.
Roivant Sciences

NASDAQ:ROIV

View ROIV Stock Overview

ROIV Rankings

ROIV Latest News

ROIV Latest SEC Filings

ROIV Stock Data

20.24B
517.69M
Biotechnology
Pharmaceutical Preparations
Link
United Kingdom
LONDON